Press Releases

- Skyhawk to expand its collaboration with Biogen to develop novel small molecule RNA splicing modifiers for disease targets- Biogen to pay Skyhawk additional upfront and potential future milestone payments and royalties WALTHAM, Mass., July 8, 2019 /PRNewswire/ -- Skyhawk Therapeutics, Inc. ("Skyhawk") today announced the expansion of its collaborat

NEW YORK and CAESAREA, Israel, July 8, 2019 /PRNewswire/ -- Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on

STOCKHOLM, July 8, 2019 /PRNewswire/ -- On 17 July, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the sec

VAUGHAN, ON, July 8, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) has received a compliance report from Health Canada notifying the Company that its greenhouse facility in Pelham, Ontario is non-compliant with certain regulations. CannTrust has accepted Health Canada's non-compliance f

- Tyler Jacks, Ph.D., head of the Koch Institute for Integrative Cancer Research at MIT, joins as Chair of Skyhawk's Scientific Advisory Board- Tai Wong, Ph.D., former Vice President Biology of Peloton Therapeutics, now being acquired by Merck, joins Skyhawk as Vice President, Oncology Biology

PRINCETON, N.J., July 8, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the appointment of Ms. Diane L. Parks

CAMBRIDGE, Mass., July 8, 2019 /PRNewswire/ -- EIP Pharma, Inc. a CNS-focused therapeutics company, today announced that it has expanded its leadership team with the appointment of Noel Donnelly as CFO. Mr. Donnelly joins EIP Pharma from Takeda Pharmaceuticals where he led a group focused on strategy and operations.

ZURICH, Switzerland, July 8, 2019 /PRNewswire/ -- Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is w

LEEDS, England, July 8, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its lead Live Biotherapeutic candidate for asthma, MRx-4DP0004. A multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma has n

TEL AVIV, Israel and ST. LOUIS, Missouri, July 8, 2019 /PRNewswire/ -- As the two organizations move closer to the commencement of the clinical trial to determine the safety and tolerability of the Apograft technology for bone marrow transplantations, Cellect Biotechnology Ltd. (Nasdaq: APOP), and Washingto